30 Apr 2014 --- Ganeden Biotech, a recognized world leader in the manufacturing and marketing of probiotics, has announced the issuance of a United States patent that covers the use of all Bacillus coagulans in all coffee, tea and cereal. The issuance of patent #US 8,697,055 B2 protects the use of all Bacillus coagulans probiotic strains including GanedenBC30 in coffee, tea and cereal applications.
